NIH IRP Project, Program, and Portfolio (P3) Support Services
ID: 75N98022D00019Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH OLAOBETHESDA, MD, 20892, USA

NAICS

Administrative Management and General Management Consulting Services (541611)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Set Aside

SBA Certified Women-Owned Small Business (WOSB) Program Set-Aside (FAR 19.15) (WOSB)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is announcing a special notice regarding the modification of Contract No. 75N98022D00019, awarded to Black Canyon Consulting, LLC (BCC), for Project, Program, and Portfolio (P3) Support Services. The objective of this modification is to increase the contract ceiling by $60 million, raising the total from approximately $95.76 million to $155.76 million, to ensure the continuation of critical, specialized services that support NIH's Intramural Research Program (IRP) amidst ongoing public health challenges. This contract is vital for maintaining operational continuity and enhancing NIH's capacity to address biomedical and clinical research activities, particularly in response to emerging health threats. Interested parties may submit their capabilities for consideration by September 24, 2024, with inquiries directed to Tednette White at tednette.white@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    This document outlines an agreement between BLACK CANYON CONSULTING LLC and the National Institutes of Health (NIH) regarding the assignment of intellectual property rights for works produced by the consulting firm’s employees while supporting NIH’s intramural research activities. Under Contract No. 75N98022D00019, any inventions, creations, or other outputs generated by BLACK CANYON employees during their assignments at NIH will be owned by NIH, including all associated rights such as patents and copyrights. The agreement reflects the collaborative effort and ensures that innovations developed within the NIH framework are fully transferred to the agency for its use. The document is formalized by the signature of Haley Esser, CEO of BLACK CANYON CONSULTING LLC, signaling the recognition of NIH's rights over such creations. This agreement is essential for maintaining a clear, legal ownership of intellectual property resulting from government contracts, underlining the importance of protecting government-funded research outcomes.
    The National Institutes of Health (NIH) seeks a contractor to provide specialized project, program, and portfolio services to support its Intramural Research Program (IRP). This initiative, known as The P3 Contract, aims to enhance NIH's ability to address biomedical and clinical research activities, particularly in response to emerging health threats. The contract encompasses three key task areas: Enterprise Management Systems, Project, Program and Portfolio Solutions, and Transition Plans. Each task area requires various support services such as strategic planning, contract administration, and project management tailored to specific NIH needs. The NIH IRP, comprising numerous research institutes focused on diverse health issues, holds a substantial scope of work due to the complexity of ongoing projects and research demands. The contractor is expected to use advanced program management software to ensure real-time tracking and efficient collaboration across NIH initiatives. Furthermore, the contractor must adhere to strict privacy, accessibility, and ethical standards while maintaining operational transparency. This contract underscores the NIH's commitment to advancing biomedical research through strategic partnerships and optimized project management.
    Lifecycle
    Title
    Type
    Similar Opportunities
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    NIH Business and Professional Support Services (BPSS) IV
    Active
    Health And Human Services, Department Of
    Special Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking NIH Business and Professional Support Services (BPSS) IV. This includes various business and professional support services such as financial analysis, business solutions, acquisition lifecycle support, business process improvement, organizational assessment, communication and training, program planning and management services, policy development, implementation, and administration, system integration work, Center of Excellence (COE) support, and human resources (HR) solutions. The purpose of this notice is to provide an update for BPSS IV, as the required internal documents are currently being processed. The posting of the solicitation is not estimated at this time. Any updates regarding the solicitation will be posted on sam.gov. Please monitor sam.gov for updates. Thank you for your patience and understanding.
    A--Biomedical Data Computing Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) National Cancer Institute (NCI), is seeking qualified contractors to provide Biomedical Data Computing Support Services. The primary objective of this procurement is to manage and analyze large, complex datasets related to cancer research, supporting the Division of Cancer Epidemiology and Genetics (DCEG) in their ongoing studies both domestically and internationally. This initiative is crucial for enhancing the understanding of cancer causes and prevention through effective data management and analysis, which includes establishing communication infrastructure, managing biomedical data, and providing statistical programming and software development. The NCI anticipates awarding multiple Indefinite Delivery Indefinite Quantity (IDIQ) contracts with an ordering period from September 2025 to September 2035. Interested parties should contact Antoinette C. Robinson at antoinette.robinson@nih.gov or +1 240 276 5823 for further information and are encouraged to monitor www.SAM.gov for updates on the solicitation.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP) and federal regulations. This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million over the contract period from September 1, 2025, to May 14, 2031. Interested parties must submit their proposals by December 3, 2024, and can direct inquiries to primary contact Samson Shifaraw at samson.shifaraw@nih.gov or secondary contact Valerie Whipple at valerie.whipple@nih.gov.
    Notice of Intent to Sole-Source
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is planning to non-competitively increase the ceiling on an existing indefinite delivery, indefinite quantity (IDIQ) contract with Planon Corporation for maintenance services related to their proprietary Computer-Aided Facility Management (CAFM) system. This increase is necessary to ensure the continued functionality and optimal performance of the Planon ProCenter system, which is critical to the operations of the National Cancer Institute (NCI). The specialized knowledge required for the maintenance services can only be provided by the incumbent contractor, as integrating a new software solution would incur substantial costs and delays. Interested parties can reach out to Ashley Riggs at ashley.riggs@nih.gov or 240-858-7852 for further information, with the acquisition being processed under FAR Part 12 and a justification and award notice to be posted within 14 days upon award.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Insurance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a sole-source contract to Dr. Rhonda Robinson Beale for consulting services related to medical device development under the Blueprint MedTech Initiative. The primary objective of this procurement is to secure a subject matter expert with extensive experience in U.S. medical insurance and coverage, who will provide strategic guidance and oversight on various projects within the initiative, which aims to accelerate the development of translational neurological medical devices. The Blueprint MedTech Initiative is crucial for supporting innovators in overcoming challenges in bringing medical technologies from concept to clinical application, with a funding allocation of $32 million from 2019 to 2027 to facilitate at least ten successful clinical studies. Interested parties can reach out to Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov for further information, although the final decision for this contract award will remain at the government's discretion.
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research purposes, aimed at advancing the understanding of nervous system disorders. This initiative is critical for enhancing biomedical research by providing well-characterized specimens to researchers, thereby facilitating studies that could lead to improved treatments and interventions. Proposals are due by November 25, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending potentially through multiple option years. Interested vendors should contact Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.
    Clinical Site and Study Monitoring for NIMH Funded Research in Global Settings
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for clinical site and study monitoring services for research funded by the National Institute of Mental Health (NIMH) in global settings. The primary objective of this procurement is to support efforts aimed at reducing mental health disparities, particularly in low and middle-income countries, through rigorous monitoring practices that comply with federal regulations and Good Clinical Practice. This five-year contract, expected to commence on November 25, 2024, has an anticipated budget of up to $2,000,000, with firm-fixed price task orders awarded as needed. Interested parties should direct inquiries to Cassandra Conley at cassandra.conley@nih.gov or Rieka Plugge at rieka.plugge@nih.gov.
    A--To award Indefinite Delivery Indefinite Quantity (IDIQ) Contract for a Biologic
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to fulfill an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the Biological Testing Facility (BTF), which focuses on the preclinical development of contraceptive products. The objective of this procurement is to support the discovery and optimization of anti-fertility agents, ensuring safety and efficacy evaluations that meet regulatory standards for clinical trials, ultimately aiding in the development of high-quality reproductive health products. Interested small businesses must demonstrate their qualifications, including compliance with Good Laboratory Practice and Good Manufacturing Practice, and provide capability statements by November 21, 2024, with the anticipated contract performance period running from September 3, 2025, to September 2, 2032. For further inquiries, interested parties may contact Adelola O. St John at lk202p@nih.gov or call 301-435-6955.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment Development
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA), intends to award a sole-source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective is to procure a subject matter expert with extensive experience in neurotechnology and mental health product development, who will provide strategic guidance and oversight for projects aimed at accelerating the translation of innovative medical devices for neurological disorders. This initiative, established in 2019 with a funding allocation of $32 million, seeks to facilitate the development of groundbreaking technologies and ensure their progression to clinical studies by 2027. Interested parties may submit their qualifications by November 8, 2024, to the designated contacts, Tracy Cain and Llakim Dubroff, at the NIH.